Yufeng Ba

480 total citations
12 papers, 294 citations indexed

About

Yufeng Ba is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Yufeng Ba has authored 12 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Yufeng Ba's work include MicroRNA in disease regulation (3 papers), Anesthesia and Pain Management (2 papers) and Esophageal and GI Pathology (2 papers). Yufeng Ba is often cited by papers focused on MicroRNA in disease regulation (3 papers), Anesthesia and Pain Management (2 papers) and Esophageal and GI Pathology (2 papers). Yufeng Ba collaborates with scholars based in China, United States and Japan. Yufeng Ba's co-authors include Song Wu, Jingfang Ju, Andrew Fesler, Haiyan Zhai, Sining Shen, Xianben Liu, Huixiang Li, Lin Tian, Yu Zhu and Baoxing Liu and has published in prestigious journals such as Annals of Surgical Oncology, Oncotarget and BMC Cancer.

In The Last Decade

Yufeng Ba

12 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yufeng Ba China 10 172 163 52 34 32 12 294
Hu Zhang China 9 183 1.1× 115 0.7× 52 1.0× 51 1.5× 69 2.2× 27 347
Joseph Ipe United States 9 123 0.7× 56 0.3× 67 1.3× 13 0.4× 22 0.7× 18 270
Ran Zhuo China 8 173 1.0× 118 0.7× 94 1.8× 70 2.1× 21 0.7× 23 328
Gabriela Mendoza United States 6 181 1.1× 70 0.4× 68 1.3× 56 1.6× 22 0.7× 7 321
Yurong Xing China 10 169 1.0× 138 0.8× 39 0.8× 37 1.1× 38 1.2× 13 297
WenXing Fan China 11 194 1.1× 130 0.8× 20 0.4× 42 1.2× 27 0.8× 25 313
Kaichao Liu China 10 189 1.1× 123 0.8× 66 1.3× 57 1.7× 15 0.5× 12 308
Ailin Song China 10 169 1.0× 161 1.0× 46 0.9× 48 1.4× 21 0.7× 22 325
Man Zhu China 9 305 1.8× 307 1.9× 28 0.5× 33 1.0× 34 1.1× 12 416

Countries citing papers authored by Yufeng Ba

Since Specialization
Citations

This map shows the geographic impact of Yufeng Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Ba more than expected).

Fields of papers citing papers by Yufeng Ba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Ba. The network helps show where Yufeng Ba may publish in the future.

Co-authorship network of co-authors of Yufeng Ba

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Ba. A scholar is included among the top collaborators of Yufeng Ba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Ba. Yufeng Ba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ba, Yufeng, Haomiao Li, Hongwei Lv, et al.. (2023). Case report: targeted sequencing improves the diagnosis of multiple synchronous lung cancers. Translational Lung Cancer Research. 12(4). 933–939. 2 indexed citations
2.
Lv, Hongwei, et al.. (2021). SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner. Translational Oncology. 14(6). 101075–101075. 11 indexed citations
3.
Yan, Zheng, Yin Li, Xianben Liu, et al.. (2021). Minimally Invasive Versus Open McKeown for Patients with Esophageal Cancer: A Retrospective Study. Annals of Surgical Oncology. 28(11). 6329–6336. 10 indexed citations
4.
Ba, Yufeng, et al.. (2020). <p>HIPK3 Promotes Growth and Metastasis of Esophageal Squamous Cell Carcinoma via Regulation of miR-599/c-MYC Axis</p>. OncoTargets and Therapy. Volume 13. 1967–1978. 14 indexed citations
5.
Shen, Sining, Ke Li, Ying Liu, et al.. (2020). Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression. Molecular Therapy — Nucleic Acids. 20. 331–344. 47 indexed citations
8.
Wen, Qiang, Xinwei Jiao, Fei Kuang, et al.. (2019). FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signaling. EBioMedicine. 40. 198–209. 12 indexed citations
9.
Zhai, Haiyan, Andrew Fesler, Yufeng Ba, Song Wu, & Jingfang Ju. (2015). Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy. Oncotarget. 6(23). 19735–19746. 109 indexed citations
10.
Ba, Yufeng, Xiaodong Li, Xiaofei Zhang, et al.. (2014). Comparison of the analgesic effects of cryoanalgesia vs. parecoxib for lung cancer patients after lobectomy. Surgery Today. 45(10). 1250–1254. 17 indexed citations
11.
Zhu, Yu, Nan Ma, Huixiang Li, et al.. (2014). Berberine induces apoptosis and DNA damage in MG-63 human osteosarcoma cells. Molecular Medicine Reports. 10(4). 1734–1738. 44 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026